A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Public ClinicalTrials.gov record NCT05379634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
Study identification
- NCT ID
- NCT05379634
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2022 (Actual)
- Primary completion
- Sep 4, 2025 (Actual)
- Completion
- Sep 16, 2026 (Estimated)
- Last update posted
- Sep 21, 2026
2022 – 2026
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Research PLLC | Phoenix | Arizona | 85032 | — |
| HonorHealth Neurology | Scottsdale | Arizona | 85251 | — |
| Attune Health Autoimmune and Inflamation Care and Research | Beverly Hills | California | 90211 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| FM Clinical Research, LLC South Florida Neurology Associates, P. A. | Boca Raton | Florida | 33487 | — |
| Integral Rheumatology And Immunology Specialists | Plantation | Florida | 33324 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| The Brigham and Women's Hospital, Inc. | Boston | Massachusetts | 02115 | — |
| Clinical Research Institute of Michigan, LLC | Saint Clair Shores | Michigan | 48081 | — |
| Wexner Medical Center at the Ohio State University | Columbus | Ohio | 43203 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania - Perelman School of Medicine | Philadelphia | Pennsylvania | 19104 | — |
| ACME Research Arthritis and Osteoporosis Center | Orangeburg | South Carolina | 29118 | — |
| Nervie and Muscle Center of Texas | Houston | Texas | 77030 | — |
| University of Texas at Houston Medical School | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05379634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05379634 live on ClinicalTrials.gov.